| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $0.9587 ▲ +1.15% | Yesterday | $0.9432 ▼ -0.48% | Tomorrow's Rani Therapeutics Holdings Inc. Class A Common Stock (RANI) setup is anchored to $0.9478 and targets $0.9587 (+1.15%). The near-term read is upside; watch $0.9762 / $0.9194 because daily realized volatility is about 5.93%. |
Tomorrow's Rani Therapeutics Holdings Inc. Class A Common Stock (RANI) setup is anchored to $0.9478 and targets $0.9587 (+1.15%). The near-term read is upside; watch $0.9762 / $0.9194 because daily realized volatility is about 5.93%. | ||||
| Week | $0.9817 ▲ +3.58% | Last Week | $0.9336 ▼ -1.50% | The 7-day Rani Therapeutics Holdings Inc. Class A Common Stock model moves from $0.9336 to $0.9817 (+3.58%). It gives upside momentum context for this stock, so breaks around $0.9762 / $0.9194 matter more than a single tick. |
The 7-day Rani Therapeutics Holdings Inc. Class A Common Stock model moves from $0.9336 to $0.9817 (+3.58%). It gives upside momentum context for this stock, so breaks around $0.9762 / $0.9194 matter more than a single tick. | ||||
| Month | $1.02 ▲ +7.61% | Last Month | $0.9175 ▼ -3.20% | The 1-month Rani Therapeutics Holdings Inc. Class A Common Stock target is $1.02 (+7.61%), compared with the live reference near $0.9478. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Rani Therapeutics Holdings Inc. Class A Common Stock target is $1.02 (+7.61%), compared with the live reference near $0.9478. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.08 ▲ +13.67% | Last Year | $0.8934 ▼ -5.74% | The 1-year Rani Therapeutics Holdings Inc. Class A Common Stock scenario points to $1.08 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Rani Therapeutics Holdings Inc. Class A Common Stock scenario points to $1.08 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $1.21 ▲ +27.86% | 5 Years Ago | $0.8369 ▼ -11.70% | The 5-year Rani Therapeutics Holdings Inc. Class A Common Stock view is $1.21 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Rani Therapeutics Holdings Inc. Class A Common Stock view is $1.21 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $0.9478 | Mid |
| Daily Change | -2.66% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $0.9478 | Daily Change | -2.66% |
| Market Cap | $117.24M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.